JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online March 14, 2008, 10.2967/jnumed.107.043752
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapadia, N. S.
Right arrow Articles by Wahl, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapadia, N. S.
Right arrow Articles by Wahl, R. L.

In Vitro Evaluation of Radioprotective and Radiosensitizing Effects of Rituximab

Nirav S. Kapadia1, James M. Engles2 and Richard L. Wahl2

1 School of Medicine, The Johns Hopkins University, Baltimore, Maryland; and 2 Division of Nuclear Medicine, Russell H. Morgan Department of Radiological Sciences, School of Medicine, The Johns Hopkins University, Baltimore, Maryland


Figure 1
View larger version (23K):
[in this window]
[in a new window]

 
FIGURE 1.  (A) Lentivirus transfection cassette. (B) Fluorescence microscopy of transfected cells, demonstrating stable GFP expression. EF1{alpha} = elongation factor 1{alpha}; IRES = internal ribosome entry site; 5'LTR = 5' long terminal repeat; 3'LTR = 3' long terminal repeat; LUC = luciferase.

 

Figure 2
View larger version (15K):
[in this window]
[in a new window]

 
FIGURE 2.  Effect of 1-h rituximab predose (20 µg/mL) on cell survival. Dose–response relationship was observed with regard to cell growth rate in response to various amounts of radiation exposure. Each data point is normalized to starting cell count and represents mean of 3 determinations.

 

Figure 3
View larger version (16K):
[in this window]
[in a new window]

 
FIGURE 3.  Effect of 24-h rituximab predose on cell survival. Dose–response relationship was observed with various amounts of radiation exposure. Each data point is normalized to cell count at day of irradiation and represents mean of 3 determinations.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.